Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 33

1.

A randomised, double-blind, phase II study of two doses of pemetrexed in the treatment of platinum-resistant, epithelial ovarian or primary peritoneal cancer.

Vergote I, Calvert H, Kania M, Kaiser C, Zimmermann AH, Sehouli J.

Eur J Cancer. 2009 May;45(8):1415-23. doi: 10.1016/j.ejca.2008.12.013. Epub 2009 Jan 23.

PMID:
19168349
2.

Emerging role of pemetrexed in ovarian cancer.

Tomao F, Panici PB, Frati L, Tomao S.

Expert Rev Anticancer Ther. 2009 Dec;9(12):1727-35. doi: 10.1586/era.09.141. Review.

PMID:
19954283
3.

Pemetrexed alone and in combination with platinum compounds in the management of malignant mesothelioma.

Suwanrusme H, Meyer ML, Green MR.

Clin Lung Cancer. 2004 Apr;5 Suppl 2:S56-60. Review.

PMID:
15117426
4.

Pemetrexed in gastric cancer: clinical experience and future perspectives.

Celio L, Buzzoni R, Longarini R, Marchianò A, Bajetta E.

Semin Oncol. 2002 Dec;29(6 Suppl 18):63-8. Review.

PMID:
12571814
5.

Use of pemetrexed in breast cancer.

Dittrich C.

Semin Oncol. 2006 Jun;33(3 Suppl 9):S24-8. Review.

PMID:
16797379
6.

New data integrating multitargeted antifolates into treatment of first-line and relapsed non-small-cell lung cancer.

Scagliotti GV, Selvaggi G.

Clin Lung Cancer. 2008;9 Suppl 3:S122-8. doi: 10.3816/CLC.2008.s.018. Review.

PMID:
19419926
7.

The current state of pemetrexed in ovarian cancer.

Miller RE, Banerjee S.

Expert Opin Investig Drugs. 2013 Sep;22(9):1201-10. doi: 10.1517/13543784.2013.820703. Epub 2013 Jul 31. Review.

PMID:
23899335
8.

Gemcitabine reverses platinum resistance in platinum-resistant ovarian and peritoneal carcinoma.

Rose PG.

Int J Gynecol Cancer. 2005 May-Jun;15 Suppl 1:18-22. Review.

PMID:
15839954
9.

Overview of phase I trials of multitargeted antifolate (MTA, LY231514).

Rinaldi DA.

Semin Oncol. 1999 Apr;26(2 Suppl 6):82-8. Review.

PMID:
10598560
10.

Pemetrexed in first-line treatment of non-small cell lung cancer.

Esteban E, Casillas M, Cassinello A.

Cancer Treat Rev. 2009 Jun;35(4):364-73. doi: 10.1016/j.ctrv.2009.02.002. Epub 2009 Mar 6. Review.

PMID:
19269106
11.

Pemetrexed disodium.

Gibbs D, Jackman A.

Nat Rev Drug Discov. 2005 May;Suppl:S16-7. Review.

PMID:
15962527
12.

Pemetrexed: single-agent and combination phase I study overview.

Boyer MJ, Rivory LP, Clarke SJ.

Semin Oncol. 2002 Dec;29(6 Suppl 18):18-23. Review.

PMID:
12571806
13.

Pemetrexed in the treatment of selected solid tumors.

Adjei AA.

Semin Oncol. 2002 Apr;29(2 Suppl 5):50-3. Review.

PMID:
12023793
14.

Could we expect to improve survival in small cell lung cancer?

El Maalouf G, Rodier JM, Faivre S, Raymond E.

Lung Cancer. 2007 Aug;57 Suppl 2:S30-4. Review.

PMID:
17686444
15.

Pemetrexed: a promising new treatment for breast cancer.

O'Shaughnessy JA, Gennari A, Conte P.

Semin Oncol. 2002 Apr;29(2 Suppl 5):36-41. Review.

PMID:
12023791
16.

Pemetrexed, a novel antifolate therapeutic alternative for cancer chemotherapy.

Villela LR, Stanford BL, Shah SR.

Pharmacotherapy. 2006 May;26(5):641-54. Review.

PMID:
16637794
17.

Pemetrexed in patients with gastrointestinal carcinoma.

de Gramont A, Kindler HL.

Semin Oncol. 2002 Apr;29(2 Suppl 5):42-9. Review.

PMID:
12023792
18.

The potential role of pemetrexed in gastrointestinal cancer.

Meriggi F, Di Biasi B, Caliolo C, Zaniboni A.

Chemotherapy. 2008;54(1):1-8. Epub 2007 Dec 7. Review.

PMID:
18063861
19.

[Pemetrexed: from preclinic to clinic].

Lansiaux A, Lokiec F.

Bull Cancer. 2007;94 Spec No Actualites:S134-8. Review. French.

PMID:
17845983
20.

The role of pemetrexed in the treatment of gastrointestinal malignancy.

Hochster HS.

Clin Colorectal Cancer. 2004 Sep;4(3):190-5. Review.

PMID:
15377402

Supplemental Content

Support Center